Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies

Go back to Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies
(NASDAQ: NUWE) Delayed: 2.29 -0.56 (19.65%)
Previous Close $2.85    52 Week High
Open $2.63    52 Week Low
Day High $2.63    P/E N/A 
Day Low $2.06    EPS
Volume 319,258